Literature DB >> 16930270

Interdigital skin lesions of the lower limbs among patients with lymphoedema in an area endemic for bancroftian filariasis.

Gerusa Dreyer1, David Addiss, Patricia Gadelha, Eduardo Lapa, John Williamson, Annelies Dreyer.   

Abstract

OBJECTIVES: An estimated 15 million persons suffer from lymphoedema of the leg in filariasis-endemic areas of the world. A major factor in the progression of lymphoedema severity is the incidence of acute dermatolymphangioadenitis (ADLA), which is triggered by bacteria that gain entry through damaged skin, especially in the toe web spaces ('interdigital skin lesions'). Little is known about the epidemiology of these skin lesions or about patients' awareness of them.
METHODS: We interviewed and examined 119 patients (89% women) with lymphoedema of the leg in Recife, Brazil, an area endemic for bancroftian filariasis.
RESULTS: We detected 412 interdigital skin lesions in 115 (96.6%) patients (mean, 3.5 lesions per patient, range 0-8). The number of interdigital skin lesions was significantly associated with lymphoedema stage (P<0.001) and frequency of ADLA (P<0.0001). Only 20 (16.8%) patients detected their own interdigital skin lesions or considered them abnormal. Patients reported a mean of 3.6 ADLA episodes during the previous 12 months (range, 0-20); reported ADLA incidence was associated with lymphoedema stage (P<0.0001) and the number of interdigital skin lesions detected by the examining physician (P<0.0001).
CONCLUSIONS: These data suggest that interdigital skin lesions are a significant risk factor for ADLA and that persons with lymphoedema in filariasis-endemic areas are unaware of their presence or importance. Prevention of ADLA through prompt recognition and treatment of interdigital skin lesions will require that patients be taught to identify lesions, especially between the toes and to recognize them as abnormal.

Entities:  

Mesh:

Year:  2006        PMID: 16930270     DOI: 10.1111/j.1365-3156.2006.01687.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

1.  Cryptic Bacteria of Lower Limb Deep Tissues as a Possible Cause of Inflammatory and Necrotic Changes in Ischemia, Venous Stasis and Varices, and Lymphedema.

Authors:  Waldemar L Olszewski; Marzanna Zaleska; Ewa Stelmach; Ewa Swoboda-Kopec; Pradeep Jain; Karoon Agrawal; Sashi Gogia; Arun Gogia; Piotr Andziak; Marek Durlik
Journal:  Surg Infect (Larchmt)       Date:  2015-05-26       Impact factor: 2.150

2.  Bacterial diversity significantly reduces toward the late stages among filarial lymphedema patients in the Ahanta West District of Ghana: A cross-sectional study.

Authors:  Samuel O Asiedu; Priscilla Kini; Bill C Aglomasa; Emmanuel K A Amewu; Ebenezer Asiedu; Solomon Wireko; Kennedy G Boahen; Afiat Berbudi; Augustina A Sylverken; Alexander Kwarteng
Journal:  Health Sci Rep       Date:  2022-07-20

3.  Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India.

Authors:  Larry Sawers; Eileen Stillwaggon
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

4.  Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis.

Authors:  David G Addiss; Jacky Louis-Charles; Jacquelin Roberts; Frederic Leconte; Joyanna M Wendt; Marie Denise Milord; Patrick J Lammie; Gerusa Dreyer
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

5.  Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia.

Authors:  Ha El-Nahas; Am El-Shazly; M Abulhassan; Na Nabih; N Mousa
Journal:  J Glob Infect Dis       Date:  2011-07

6.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

7.  Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti.

Authors:  Patrick J Lammie; Mark L Eberhard; David G Addiss; Kimberly Y Won; Madsen Beau de Rochars; Abdel N Direny; Marie Denise Milord; Jack Guy Lafontant; Thomas G Streit
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

8.  The Effect of a Regimen of Antifungal Cream Use on Episodes of Acute Adenolymphangitis (ADL) among Lymphedema Patients: An Application Using Marginal Structural Models.

Authors:  K E Mues; M Klein; D G Kleinbaum; W D Flanders; L M Fox
Journal:  J Epidemiol Glob Health       Date:  2018-12

Review 9.  Lymphatic Filariasis: A Systematic Review on Morbidity and Its Repercussions in Countries in the Americas.

Authors:  Zulma M Medeiros; Amanda V B Vieira; Amanda T Xavier; Gilberto S N Bezerra; Maria de Fátima C Lopes; Cristine V Bonfim; Ana M Aguiar-Santos
Journal:  Int J Environ Res Public Health       Date:  2021-12-28       Impact factor: 3.390

10.  Impact of a community-based lymphedema management program on episodes of Adenolymphangitis (ADLA) and lymphedema progression--Odisha State, India.

Authors:  Katherine E Mues; Michael Deming; David G Kleinbaum; Philip J Budge; Mitch Klein; Juan S Leon; Aishya Prakash; Jonathan Rout; LeAnne M Fox
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.